Related references
Note: Only part of the references are listed.The value of productivity: human-capital versus friction-cost method
W. B. van den Hout
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population
Lijing Ouyang et al.
JOURNAL OF CHILD NEUROLOGY (2008)
Lysosomal storage disease 2 - Pompe's disease
Ans T. van der Ploeg et al.
LANCET (2008)
Assessing the economic challenges posed by orphan drugs
Michael F. Drummond et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2007)
Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints
Janneke P. C. Grutters et al.
QUALITY OF LIFE RESEARCH (2007)
Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease
P. S. Kishnani et al.
NEUROLOGY (2007)
The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies
L. M. Lamers et al.
HEALTH ECONOMICS (2006)
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Priya S. Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
Disease severity in children and adults with Pompe disease related to age and disease duration
MLC Hagemans et al.
NEUROLOGY (2005)
Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
P Harmatz et al.
JOURNAL OF PEDIATRICS (2004)
Late-onset Pompe disease primarily affects quality of life in physical health domains
MLC Hagemans et al.
NEUROLOGY (2004)
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature
HMP van den Hout et al.
PEDIATRICS (2003)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Enzyme-replacement therapy in mucopolysaccharidosis I.
ED Kakkis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Juvenile and adult-onset acid maltase deficiency in France -: Genotype-phenotype correlation
P Laforêt et al.
NEUROLOGY (2000)
Recombinant human α-glucosidase from rabbit milk in Pompe patients
H Van den Hout et al.
LANCET (2000)
Share Paper
